Ingestion of fermented dairy products induces changes in the equilibrium and metabolism of the intestinal microflora and may thus exert a healthful influence on the host. We compared the effects of consumption of a traditional yogurt, a milk fermented with yogurt cultures and Lactobacillus casei (YC), and a nonfermented gelled milk on the fecal microflora of healthy infants. Thirty-nine infants aged 10-18 mo were randomly assigned to one of three groups in which they received 125 g/d of one of the three products for 1 mo. The following indexes were not modified during the supplementation period or for 1 wk after the end of supplementation: total number of anaerobes, bifidobacteria, bacteroides, and enterobacteria; pH; water content; concentrations of acetate, butyrate, propionate, and lactate; and bacterial enzyme activity of ␤-galactosidase and ␣-glucosidase. In contrast, in the yogurt group the number of enterococci in fecal samples increased (P < 0.05), whereas the percentage of branched-chain and long-chain fatty acids, which are markers of proteolytic fermentation, decreased (P < 0.05). In the YC group, the percentage of children with > 6 log 10 colony-forming units lactobacilli/g feces increased (P < 0.05), whereas the potentially harmful enzyme activity of ␤-glucuronidase and ␤-glucosidase decreased (P < 0.05). These decreases were particularly marked in those infants in the YC group in whom activity of the enzymes was initially unusually high. 1998;67:111-7. 
INTRODUCTION
Yogurt and fermented milks can be included in the diet beginning in the weaning period (1) . They are good sources of minerals and vitamins (2) (3) (4) and contain only small amounts of lipids (5) . In addition, yogurt and fermented milks help regulate the absorption of dietary nitrogen components in the body (6) and supply many lactic acid bacteria, which may offer other health benefits as well (7, 8) . These ingested lactic acid bacteria partially resist gastric acidity and bile salts and therefore pass live through the gastrointestinal tract (9) (10) (11) (12) where they may influence the metabolism and equilibrium of endogenous microflora.
The control of such modifications is an important feature of health because intestinal microflora can exert either beneficial or deleterious effects on the host (13) (14) (15) .
According to the official journal of the French republic, yogurt is defined as a fermented milk obtained by specific lactic acid fermentation, through the action of Lactobacillus bulgaricus and Streptococcus thermophilus (16) . Other lactic acid bacteria, in particular those from the genera Lactobacillus, Streptococcus, Leuconostoc, and Bifidobacterium (17) , can be combined with yogurt starters to produce fermented milks with specific desirable characteristics, such as new flavor (2, 18) . In addition, some lactic acid bacteria are included for their probiotic properties. As probiotics, they are "living microorganisms, which on digestion in certain numbers, exert health benefits beyond inherent basic nutrition" (19) . Research on the physiologic and clinical aspects of probiotics is ongoing. Few studies have dealt with the influence of fermented milks on the intestinal microflora of healthy subjects. In adults, recent studies suggested that yogurt consumption does not modify the fecal short-chain fatty acid (SCFA) concentration (20) nor does it alter some deleterious bacterial enzyme activity, such as that of nitroreductase, azoreductase, and ␤-glucuronidase in healthy adults (21) . In contrast, L. casei GG yogurt decreases the potentially harmful enzyme activity of ␤-glucuronidase, nitroreductase, and glycocholic acid hydrolase (22) .
There are no recent data on the effects of fermented milks on the intestinal microflora of healthy children. Thus, in the present study we evaluated the influence of two fermented milks on several indexes of the intestinal microflora of healthy infants aged 10-18 mo. We compared major bacterial genera and bacterial metabolic characteristics in infants consuming either a traditional yogurt or a milk fermented with yogurt cultures and L. casei; a nonfermented gelled milk (GM) was used as a control. SCFAs and lactic acids were investigated as markers of glycolytic fermentation, and ammonia and branched-chain fatty acids as markers of proteolytic fermentation. Activity of ␤-glucosidase, ␤-glucuronidase, nitroreductase, and nitrate reductase, which are implicated in the release and production of toxic substances, was also investigated.
SUBJECTS AND METHODS

Subjects
Thirty-nine healthy children aged 10-18 mo (average age: 14 mo) from eight daycare centers in an urban area (Val de Marne, France) were studied. Infants were not receiving any medical treatment. Written parental permission was obtained for each child. The study was approved by the Ethics Committee of Saint Germain-en-Laye Hospital, France.
Dairy products
Three products were used. A standard yogurt was obtained by fermentation of milk with the traditional yogurt cultures L. bulgaricus and S. thermophilus (Danone reference DN-542 033; Danone, Le Plessis Robinson, France). The fermented milk product (YC) was prepared with milk fermented with the same yogurt starters plus L. casei (Danone reference DN-114 001). A nonfermented GM was used as a control. Lipid and protein contents of all three products were similar. Sucrose was added to the GM for organoleptic improvement. Both fermented products contained at least 10 6 colony-forming units (CFU) L. bulgaricus/g and 10 9 CFU S. thermophilus/g. In addition, YC contained at least 10 8 CFU L. casei/g ( Table 1 ).
Study design
The study was divided into three periods: a 1-wk baseline period, a 1-mo supplementation period, and a 1-wk follow-up period. Infants were randomly assigned to one of three groups: yogurt (n = 14), YC (n = 12), and GM (n = 13). During the supplementation period each group received 125 g/d of its respective product. Fecal samples were collected in sterile containers under anaerobic conditions (Anaerocult C; Merck, Nogent sur Marne, France) twice before (days Ϫ8 and 0), twice during (days 15 and 30), and once 1 wk after (day 38) the supplementation period. The samples were stored and sent to the laboratory in refrigerated containers within 3-12 h of collection. Fecal pH was measured directly in fresh samples with a microelectrode (Ingold, France). Each fecal specimen was then divided into three samples. One was frozen at Ϫ20°C before the measurement of bacterial metabolites (SCFAs, D-and L-lactate, and ammonia) and moisture content. The second sample was frozen at Ϫ80°C before enzyme activity was analyzed. The third sample was diluted 10 Ϫ1 in prereduced liquid casein yeast medium [2 g casein enzyme hydrolysate/L (USBC, Cleveland), 2 g yeast extract/L (Serlabo, Bonneuil sur Marne, France), 5 g NaCl/L, and 1 mL KH 2 PO 4 /L], then mixed with sterile glycerol in a 1:1 volume as a cryoprotective agent, and frozen at Ϫ80°C before bacteria were counted (23) .
Bacterial analysis
Bacterial counts were performed on frozen fecal suspensions that had been thawed in ice. A series of 10-fold dilutions in liquid casein yeast medium was performed and dilutions of 10 -5 and 10
Ϫ7
were plated in duplicate onto specific media with a spiral plating instrument (Interscience, Saint Nom La Breteche, France). Total anaerobic bacteria were counted on BHI agar [37 g brain heart infusion/L (Difco), 5 g yeast extract/L (Difco), and 0.005 g hemin/L]. Bifidobacteria were counted on Beerens agar (24) . Bacteroides were counted on NBGT agar (25) . Enterococci were counted on GAPTs1 agar (pH 7. Plates containing BHI, Beerens, or NBGT agar were prereduced for 24 h in an anaerobic chamber before use. They were then incubated for 72 h at 37°C in an anaerobic glove box (CO 2 :H 2 :N 2 , 5:15:80). Plates containing GAPTs1 or DCA agar were incubated for 18 h at 37°C in aerobic conditions and plates containing MRS agar were incubated for 120 h at 30°C in aerobic conditions. After incubation, colonies were counted and identified by cell morphology. Viable counts were expressed as log 10 CFU/g fresh feces sample.
Biochemical analysis
Fecal moisture was determined by using a moisture autoanalyzer (MA30; Sartorius, Goetingen, Germany). SCFAs were analyzed with gas-liquid chromatography (1020 gas chromatograph; Perkin-Elmer, Saint Quentin on Yvelines, France) after water extraction of acidified samples. The chromatograph was equipped with a flame-ionization detector and a wide-bore Nukol column (15 ϫ 0.53 mm; Supelco, Bellefonte, PA). The carrier gas (He) flow rate was 10 mL/min, the inlet temperature was 175°C, the column temperature was 100°C, and the detector temperature was 280°C. 2-Ethylbutyrate was used as an internal standard.
Amounts of D-and L-lactate were measured enzymatically (26) . Ammonia was measured by using the Berthelot method as adapted by Dropsy and Boy (27) . The glycolytic activity of ␤-glucuronidase, ␤-glucosidase, ␤-galactosidase, and ␣-glucosidase was measured by determining the rate of p-nitrophenol release from p-nitrophenylglucoside, as described previously (28) . Nitroreductase and nitrate reductase were measured as described by Wise et al (29) . Protein concentration was determined by using the method of Lowry et al (30) . Results are expressed as mol metabolized substrate/min (IU) and /g protein.
Statistical methods
Two statistical methods adapted for longitudinal data were used. A two-factor repeated-measurements test with one grouping factor and one time factor (split-plot in time method, SPLUS software; Mathsoft, Seattle) was used to analyze biochemical results and bacterial counts except those of lactobacilli. For bacterial results, the few censored data were replaced by an analytic detection limit value, ie, values <6 log 10 CFU/g were recorded as 6 log 10 CFU/g. Each study index was analyzed separately at two successive time points. The first statistical analysis was the combination of data from days 15 and 30 with the average of data from days Ϫ8 and 0 as a covariable to uncover any change in the evolution of the indexes measured during the supplementation period. The same analysis was carried out by combining data from days 30 and 38 to show any differences after supplementation was stopped.
Because missing values are not allowed in this statistical model, infants with unavailable data for one of the two observation periods were eliminated. Most of the missing values were due to the infants being absent from the daycare centers; some were caused by an oversight on the part of the staff. For the split-plot method, the final number of infants analyzed was 8 of 13 in the GM group, 11 of 14 in the yogurt group, and 7 of 12 in the YC group.
The generalized estimating equation (31) was used to count lactobacilli (SPLUS software, STATLIB library). The lactobacilli count was often below the limit of detection (6 log 10 CFU/g). These censored data were transformed to binary data by converting values < 6 or > 6 to 0 or 1, respectively. We assumed that missing values were random. All infants were included in this study. The generalized estimating equation model was satisfactory when the number of indexes was reduced. Therefore, postsupplementation data were not considered and a new statistical control group was formed by combining the presupplementation data of the yogurt and YC groups with the data of the GM group. This statistical model allowed us to study the evolution of the frequency of samples with a lactobacilli concentration > 6 log 10 CFU/g compared with the statistical control group. P < 0.05 was considered significant.
RESULTS
Bacterial populations
Each bacterial population studied with the exception of lactobacilli was similar during the baseline period for all three groups. At days Ϫ8 and 0, the mean initial concentration of total anaerobes was 9.7 log 10 CFU/g. Bifidobacteria predominated with a mean of 9.1 log 10 CFU/g. Bacteroides was the second most predominant, with 8.6 log 10 CFU/g. Enterobacteria and enterococci were less abundant with 8.0 and 7.8 log 10 CFU/g, respectively ( Table 2) . One hundred percent of the yogurt group, 82% of the GM group, and 80% of the YC group had initial concentrations of lactobacilli < 6 log 10 CFU/g feces (Figure 1) .
Total anaerobes, bifidobacteria, bacteroides, and enterobacteria were not significantly affected by the supplementation period in any group. In the yogurt group, the number of fecal enterococci increased significantly (Table 2) . One week after the end of supplementation (day 38), the number of enterococci remained higher than the baseline value in this group (P < 0.05). In the YC group, the percentage of children with a fecal concentration of lactobacilli > 6 log 10 CFU/g increased significantly during the supplementation period (Figure 1) . One week after the end of supplementation (day 38), this percentage was 36%.
pH, water content, and bacterial metabolites
The mean pH value of all baseline fecal samples (6.4) indicated that fecal specimens were initially acidic. Water content was relatively constant, with a mean of 76%. Bacterial metabolites in the feces during the baseline period were as follows. The mean total amount of SCFAs was 77 mol/g, with large individual variability. The mean profile of SCFAs was as follows: concentrations of acetate, propionate, butyrate, branched-chain acids fatty acids, and cumulated valerate and caproate were 6, 18, 11, 7, and 2 mol/g, respectively. The mean ammonia concentration was 6.7 mol/g. Mean concentrations of D-and L-lactate were similar (1.2 and 1.1 mol/g, respectively) ( Table 3) .
There was no significant modification of the bacterial metabolites studied in the YC and GM groups. The percentage of branched-chain fatty acids and long-chain fatty acids was significantly reduced in infants consuming yogurt ( log 10 CFU/g Total anaerobes GM 9.6 ± 0.4 9.8 ± 0.4 9.8 ± 0.2 10.0 ± 0.8 Y 9.6 ± 0.5 9.7 ± 0.4 9.9 ± 0.4 9.5 ± 0.5 YC 9.8 ± 0.4 9.9 ± 0.3 9.9 ± 0.3 9.8 ± 0.4 Bifidobacteria GM 9.3 ± 0.7 9.2 ± 1.0 9.4 ± 0.7 9.5 ± 0.8 Y 9.1 ± 1.0 9.2 ± 0.9 9.2 ± 0.9 8.8 ± 1.1 YC 9.0 ± 0.9 9.3 ± 0.5 9.0 ± 0.9 8.8 ± 0.8 Bacteroides GM 8.7 ± 0.7 8.5 ± 0.5 8.7 ± 0.3 8.3 ± 0.7 Y 8.5 ± 0.6 8.6 ± 0.9 8.5 ± 0.7 8.9 ± 0.5 YC 8.5 ± 0.6 8.6 ± 0.8 8.9 ± 0.4 9.0 ± 0.6 Enterobacteria GM 8.0 ± 0.7 7.5 ± 0.9 7.8 ± 1.1 7.4 ± 0.8 Y 7.8 ± 0.9 8.0 ± 0.8 7.8 ± 0.8 7.6 ± 0.5 YC 8.1 ± 0.9 7.6 ± 0.9 8.4 ± 0.9 7.6 ± 0.6 Enterococci GM 8.0 ± 1.0 7.3 ± 0. after the end of supplementation, however, percentages of both branched-chain fatty acids and long-chain fatty acids tended to return to baseline values.
Enzyme activity
There was wide interindividual variation in bacterial enzyme activity during the baseline period ( Table 4) . The initial mean value of ␤-galactosidase at days Ϫ8 and 0 of all three groups combined (155 IU/g protein) was higher than that of either ␣-glucosidase (30 IU/g protein) or nitrate reductase (4.0 IU/g protein). Nitroreductase activity was the lowest, with a mean value of 0.13 IU/g protein during the baseline period (Table 4) . Two overall patterns emerged for initial values of ␤-glucosidase and ␤-glucuronidase activity. In most infants (n = 35), activity of ␤-glucosidase and ␤-glucuronidase was relatively low, with mean values of 4 and 1.9 IU/g protein, respectively (Table 4) . A small- 
FIGURE 1.
Proportion of children in each study group with a lactobacilli count above () or below (ᮀ) 6 log 10 colony-forming units (CFU)/g feces before (days Ϫ8 and 0), during (days 15 and 30), and after (day 38) supplementation. GM, group supplemented with fermented gelled milk (n = 13); Y, group supplemented with yogurt (n = 12); YC, group supplemented with milk fermented with yogurt cultures and Lactobacillus casei (n = 12). *Percentage of children with > 6 log 10 CFU/g feces significant, P < 0.05 (generalized estimating equation method).
Downloaded from https://academic.oup.com/ajcn/article-abstract/67/1/111/4655592 by guest on 11 January 2019 er group consisting of one infant in the yogurt group and three in the YC group had very high initial values of both ␤-glucosidase and ␤-glucuronidase. At day 0, the one infant in the yogurt group had values for ␤-glucosidase of 60 IU/g protein and for ␤-glucuronidase of 47 IU/g protein. Similarly, the three infants in the YC group had ␤-glucosidase activity of 48-139 IU/g protein (mean: 96 IU/g protein) and ␤-glucuronidase activity of 40-61 IU/g protein (mean: 50 IU/g protein).
Nitroreductase was significantly reduced in the GM group (Table 4) . No bacterial enzyme activity was significantly affected in infants consuming yogurt. In the YC group, ␤-glucuronidase and ␤-glucosidase were significantly reduced after the 2-wk supplementation period (P < 0.05). In those children in whom enzyme activity was initially high, this decrease was particularly obvious. The effect of YC on ␤-glucosidase and ␤-glucuronidase tended to remain 1 wk after the end of the supplementation period.
DISCUSSION
None of the three products tested led to disturbances in fecal bacterial or biochemical indexes in the group of healthy children studied. Bacterial profiles of the main genera (bifidobacteria, bacteroides, and enterobacteria) were not modified. Similarly, pH, water content, major bacterial metabolites (acetate, butyrate, propionate, and lactate), and activity of ␤-galactosidase and ␣-glucosidase were not affected by supplementation.
The significant effects that were noted in this study were found primarily in the groups supplemented with yogurt or YC. Supplementation with YC did not lead to the effects found with yogurt; therefore, the changes were not additive (ie, effects from yogurt plus those from L. casei) but were due to the particular association between the yogurt cultures and L. casei.
In the infants consuming yogurt, the increase of enterococci during the supplementation period may have been due either to the survival of S. thermophilus during its transit through the digestive tract or to an increase in endogenous enterococci. The methods used in our study did not allow for distinguishing between the organisms consumed and the complex intestinal microflora, ie, between S. thermophilus and total enterococci. Several in vivo (32) and in vitro (33, 34) studies reported that S. thermophilus survive poorly at best in the intestine compared with lactobacilli. However, Bianchi-Salvadori (35) reported the survival of both yogurt starters in the feces of 3-to 20-mo old children. Similarly, Pochart et al (36) reported that yogurt cultures survived passage through the stomach and reached the small intestine of adults.
Yogurt consumption did not modify the concentration of any of the SCFAs studied, as Bartram et al (20) also noted, or the ammonia concentration. Yogurt consumption did, however, result in a significant decrease in the percentages of branchedchain and long-chain fatty acids (P < 0.05). The decrease in these fatty acids, most likely resulting from bacterial protein degradation (37) , indicates that yogurt consumption may have a healthful influence on the host because proteolytic activity produces toxic metabolites in the intestine (38) .
As noted, the consumption of YC led to different results. The enterococci population was not modified, but supplementation led to a significant increase in the number of children with fecal samples containing > 6 log 10 CFU lactobacilli/g feces. This result suggests that fermented L. bulgaricus (35, 36) , L. casei, or both survive transit through the digestive tract. Other studies have reported the recovery of L. casei in the feces of both infants (39, 40) and adults (41, 42) . Similar increases in fecal lactobacilli have been reported with the consumption of various products with different lactobacillus strains, including milk fermented with L. casei and L. acidophilus (43) and nonfermented milk containing L. acidophilus (44, 45) , L. gasseri (21) , and lyophilized L. casei powder (46) .
In agreement with our results, several authors have shown that the total number of fecal lactobacilli remains high after consumption of exogenous lactobacilli. Amounts remained high in adults for 2 wk (43, 46) and for 4 wk (44) after the end of a supplementation period with lactobacilli. Lactobacillus GG was recovered in infants 2 wk (39) and 3 wk (40) after the end of supplementation. These positive results, however, contrast with those of Gilliland et al (45) and Pedrosa et al (21) , who reported a decrease in fecal lactobacilli after supplementation.
Fecal bacterial populations reflect the microflora of the colon (47) . Thus, consumption of YC, which increases fecal lactobacilli, raises lactobacilli in the colon and may be an easy way to increase the concentration to 6 log 10 CFU/g. This concentration may be sufficient to produce several physiologic benefits (10) and may prove useful in prevention of various infectious dis-FERMENTED MILKS AND INFANT MICROFLORA 115 eases, in stimulation of the immune system, and in protection against some carcinogens (48, 49) . The decrease in bacterial activity of ␤-glucuronidase and ␤-glucosidase in the YC group suggests a healthful influence of L. casei on the host because activity of these enzymes is implicated in the enterohepatic circulation of toxic and carcinogenic substances (13) . Our results agree with those of several authors who reported a decrease in ␤-glucuronidase in adults when products fermented with L. casei were consumed (11, 42) . Similar results were obtained with milk fermented with a strain of bifidobacterium (50) , and with nonfermented milks containing L. gasseri (21) or a strain of L. acidophilus (44) . Goldin et al (51, 52) also noted a decrease of ␤-glucuronidase activity in humans and in rats consuming a strain of L. acidophilus. In their experiments, initial ␤-glucuronidase activity was elevated in humans and rats because of a diet rich in meat.
In our study, the decrease in ␤-glucosidase activity in the YC group was particularly noted in those infants who had had initial values 10 times greater than those of the other children in the group. Results from other studies of ␤-glucosidase are inconsistent and vary depending on the strain of lactobacillus used. Ayebo et al (44) reported a decrease in ␤-glucosidase activity after ingestion of a nonfermented milk containing a strain of L. acidophilus. Ling et al (11, 22) found in adults that ingestion of a milk fermented with L. casei did not affect the baseline ␤-glucosidase activity of 10 IU/g protein in feces. In contrast, Marteau et al (53) found an increase in fecal ␤-glucosidase activity in subjects consuming milk fermented with L. acidophilus and Bifidobacterium bifidum.
We found no specific correlations between bacterial and metabolic modifications in any group. Higher concentrations of lactobacilli in the feces were not systematically associated with either lower ␤-glucuronidase or ␤-glucosidase activity or with a higher concentration of the fermentable metabolites that characterize the two lactobacilli strains used (ie, D-lactate for L. bulgaricus and Llactate and acetate for L. casei) (17) . In addition, the percentage of branched-chain and long-chain fatty acids was not always lower in infants with higher fecal enterococci concentrations.
Given our results, we conclude that regular consumption of yogurt and YC might be advantageous for infants after the weaning period. The association of yogurt cultures with L. casei appears to be especially beneficial for infants with high ␤-glucuronidase or ␤-glucosidase activity. This effect should be tested in adults with similar characteristics.
